期刊文献+

人乳头瘤病毒16型E6/E7基因shRNA真核表达载体构建及其对人宫颈癌SiHa细胞增殖及迁移能力的影响 被引量:5

Construction of shRNA Eukaryotic Expression Vector Targeting Human Papillomavirus Type 16 E6/E7 Gene and Its Effects on Proliferation and Migration of SiHa Cells
下载PDF
导出
摘要 目的构建针对人乳头瘤病毒16型E6/E7基因的shRNA真核表达载体,获得稳定表达干扰质粒的人宫颈癌SiHa细胞系并探讨其对SiHa细胞增殖及迁移能力的影响。方法合成3条特异性干扰HPV16 E6/E7基因的shRNA片段并定向插入psilencer 2.1-U6 hygro载体,构建重组质粒psilencer 2.1-U6hygro-shE6/E7并转染入人宫颈癌SiHa细胞,Real-time PCR检测转染后细胞E6/E7 mRNA的表达,选择沉默效应最好的重组质粒并用潮霉素B稳筛,获得稳定表达重组质粒的SiHa细胞,并用real timePCR和Western blot方法进行鉴定;分别运用CCK-8细胞增殖实验和细胞划痕愈合实验检测细胞的增殖及迁移能力。结果测序证实针对HPV16 E6/E7的shRNA真核表达载体psilencer 2.1-U6 hygro-shE6/E7构建正确;转染psilencer 2.1-U6 hygro-shE6/E7的SiHa细胞HPV16 E6/E7表达明显受抑,同时其增殖及迁移能力也明显受抑制。结论 psilencer 2.1-U6 hygro-shE6/E7真核表达载体的成功构建并获得稳定沉默表达HPV16 E6/E7的人宫颈癌SiHa细胞系,证实沉默表达HPV16 E6/E7的SiHa细胞增殖及迁移能力会明显受到抑制,这为进一步研究HPV 16 E6/E7基因在宫颈癌发生发展过程中的功能奠定了实验基础。 Objective To construct the short hairpin RNA(shRNA) eukaryotic expressing vector targeting human papillomavirus type 16 E6/E7 to establish stable transfected SiHa cell line and to observe its effects on cell proliferation and migration. Methods Three pairs of shRNA fragments which could specifically inhibit HPV16 E6/E7 genes were synthesized and cloned into the shRNA vector psilencer2.1-U6 hygro. The recombinant vectors were transfected into SiHa cells by Lipo2000 and E6/E7 mRNA expression was validated by real-time PCR. The stable psilencer 2.1-U6 hygro-shE6/E7-SiHa cell line was selected with hygromycin B and validated by real-time PCR and Western blot.The CCK-8 cell proliferation assay and cell scratch wound healing assay were performed to examine cell proliferation and migration.Results Sequencing suggested that shRNA eukaryotic expression vector targeting HPV16 E6/E7 gene, psilencer 2.1-U6 hygro-shE6/E7-SiHa cell line, was established successfully with a significantly inhibition of HPV16 E6/E7 expression, cell proliferation and migration.Conclusion Inactivation of HPV16 E6/E7 in cervical cancer cells could reduce cell proliferation and migration.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2014年第5期392-396,共5页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金资助项目(81071663)
关键词 人乳头瘤病毒16型E6/E7 载体构建 细胞增殖 细胞迁移 宫颈癌 Human papillomavirus type 16 E6/E7 Construction of vector Cell proliferation Cell migration Cervical cancer
  • 相关文献

参考文献6

  • 1Fjodor Kisseljov,Olga Sakharova,Tatjana Kondratjeva.Chapter 2 Cellular and Molecular Biological Aspects of Cervical Intraepithelial Neoplasia[J].International Review of Cell and Molecular Biology.2008
  • 2Karin Hellner,Jessica Mar,Frank Fang,John Quackenbush,Karl Münger.HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition[J].Virology.2009(1)
  • 3Margaret E. McLaughlin-Drubin,Karl Münger.Oncogenic activities of human papillomaviruses[J].Virus Research.2009(2)
  • 4Ante ?oru?i?,Lana ?krgati?,Vesna Mahovli?,Vjekoslav Mandi?,Pavao Planini?,Magdalena Karad?a.Cervical Cancer as a Public Health Issue – What Next?[J].Collegium Antropologicum.2010(1)
  • 5Vincenzo Berghella,Dana Figueroa,Jeff M. Szychowski,John Owen,Gary D.V. Hankins,Jay D. Iams,Jeanne S. Sheffield,Annette Perez-Delboy,Deborah A. Wing,Edwin R. Guzman.17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length[J].American Journal of Obstetrics and Gynecology.2010(4)
  • 6冯淑瑜,张彦娜,刘建刚.宫颈癌淋巴结转移的高危因素及预后分析[J].癌症,2005,24(10):1261-1266. 被引量:71

二级参考文献9

  • 1Bolger BS, Dabbas M, Lopes A, et al. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma [J]. Gynecol Oncol,1997,65(2): 309-313.
  • 2Takeshima N, Hirai Y, Katase K, et al. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer [ J ]. Gynecol Oncol, 1998,68 (3): 263-266.
  • 3Monk B J, Cha DS, Walker JL, et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage Ⅰ B and Ⅱ A cervical carcinoma [J]. Gynecol Oncol,1994,54( 1 ): 4-9.
  • 4Scambia G, Ferrandina G, Distefano M, et al. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients? [J]. Gynecol Oncol, 2001,83(2):319-324.
  • 5Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages Ⅰ B, Ⅱ A, and Ⅱ B cervical carcinoma treated with radical hysterectomy [J]. Cancer, 1999,85(7): 1547-1554.
  • 6Benedetti-Panici P, Maneschi F, D'Andrea G, et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study [J]. Cancer, 2000,88 (10):2267-2274.
  • 7Parazzini F, Valsecchi G, Bolis G, et al. Pelvic and paraortic lymph nodal status in advanced ovarian cancer and survival[ J]. Gynecol Oncol, 1999,74 ( 1 ): 7- 11.
  • 8Stock RG, Chen AS, Flickinger JC, et al. Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure [J]. Int J Radiat Oncol Biol Phys, 1995,31 (1):31-36.
  • 9陈亦乐,陈民.恶性肿瘤特异性生长因子测定在妇科肿瘤中的应用价值[J].湖南医学,1999,16(2):97-98. 被引量:6

共引文献70

同被引文献85

  • 1黄庆,府伟灵,周玉,张雪,黄君富,陈斌.基因芯片对人乳头瘤病毒的快速检测和分型[J].中华医院感染学杂志,2005,15(4):476-478. 被引量:50
  • 2Heng B, Glenn W K, Ye Y, Tran B, Delprado W, Lutze-Mann L, Whitaker N J, Lawson J S. Human papilloma virus is associated with breast cancer [J]. Brit J Cancer, 2009, 101:1345-1350.
  • 3D'Souza G, Dempsey A. The role of HPV in head and neck cancer and review of the HPV vaccine [J]. J Pre- ventive Medicine, 2011, (53) :5-11.
  • 4De M C, Ferlay J, Franceschi S, Vignat J, Bray F, For- man D, Plummer M. Global burden of cancers attribut- able to infections in 2008: a review and synthetic analy- sis [J]. Lancet Oncol, 2012, 13(6) :607-615.
  • 5Conway M J, Meyers C. Replication and assembly of hu- man papillomaviruses [J]. J Dent Res, 2009, 88: 307- 317.
  • 6Johansson C, Schwartz S. Regulation of human papillo mavirus gene expression by splicing and polyadenylation [J]. Nat Rev Mierobiol, 2013, 11:239-251.
  • 7Greco D, Kivi N, Qian K, Leivonen S K, Auvinen P, Auvinen E. Human papillomavirus 16 E5 modulates the expression of host microRNAs [J/OL]. PLoS One, 2011, 6:e21646.
  • 8Wang X, Meyers C, Wang H Khow L T, Zheng Z M. Construction of a full transcription map of human papillomavirus type18 during productive viral infection [J]. J Virol, 2011, 85:8080-8092.
  • 9Florin L, Sapp M, Spoden G A. Host-cell factors in- volved in papillomavirus entry [J]. Med Microbiol Im- munol, 2012, 201:437-448.
  • 10Klingelhutz A J, Roman A. Cellular transformation by human papillomaviruses., lessons learned by comparing high-and low-risk viruses [J]. Virology, 2012, 424: 77-98.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部